Perl Jeffrey, Bargman Joanne M
Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
Am J Kidney Dis. 2009 Jun;53(6):1068-81. doi: 10.1053/j.ajkd.2009.02.012. Epub 2009 Apr 25.
Increasing the dialysis dose has failed to have an impact on the mortality of dialysis patients. In contrast, residual kidney function (RKF) has consistently been a potent predictor of improved survival for both hemodialysis and peritoneal dialysis patients. The benefits of RKF preservation challenge historical concepts of dialysis adequacy that have focused principally on achieving small-solute clearance targets. In this review, we highlight the evidence supporting the impact of RKF on survival and quality of life of dialysis patients and provide a mechanistic framework for this relationship. Current strategies to preserve RKF also are reviewed, emphasizing those used in patients treated with peritoneal dialysis.
增加透析剂量未能对透析患者的死亡率产生影响。相比之下,残余肾功能(RKF)一直是血液透析和腹膜透析患者生存率提高的有力预测指标。保留RKF的益处挑战了主要侧重于实现小分子溶质清除目标的透析充分性的传统观念。在本综述中,我们强调了支持RKF对透析患者生存和生活质量影响的证据,并为这种关系提供了一个机制框架。还综述了目前保留RKF的策略,重点介绍了腹膜透析患者使用的策略。